Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BromSite (ISV-303)
print preview
bookmark
share with colleague
General Information
Company
InSite Vision Inc.
Description
Low-dose bromfenac, an NSAID, delivered via InSite's DuraSite sustained delivery technology
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase III
Indication
Ophthalmic
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information